Use of latent growth curve models for assessing the effects of darbepoetin alfa on hemoglobin and fatigue
Donald E. Stull(IQVIA (United States)), Dennis A. Revicki(United BioSource Corporation (United Kingdom)), Jason C. Legg(Amgen (United States)), Margaret Vernon(United BioSource Corporation (United Kingdom)), Diane L. Fairclough(Cancer Research Center), Hema N. Viswanathan(Amgen (United States))
Cited by 11
Related Papers
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
|Journal of Clinical Epidemiology|2010|5.1k
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
|New England Journal of Medicine|2015|1.5k
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
|Quality of Life Research|2013|855
Recommendations on health-related quality of life research to support labeling and promotional claims in the United States
|Quality of Life Research|2000|575